NOVAMET
Home/Scientific Directory/BPC-157 Synthesis
Recovery & Research10MG
BPC-157 Synthesis
scienceScientific ProtocolverifiedVetted Formulation
biotechAngiogenesis & VEGFR2 Signaling Pathways

BPC-157 Synthesis

A stable pentadecapeptide investigated for its potential regenerative properties across soft tissues, tendons, and gastric endothelium.

Transparent Pricing₦150,000 / protocol

infoResearch & Clinical Context

Studied in musculoskeletal repair models and tissue restructuring research.

Mechanism & Biological Overview

Body Protection Compound 157 (BPC-157) is a 15-amino acid sequence derived from human gastric juice proteins. Research highlights its interaction with vascular endothelial growth factor (VEGFR2) pathways, supporting localized tissue repair, tendon healing, and gut endothelial integrity.

Key Biological Highlights & Benefits

  • checkInteracts with tissue repair and cell migration signaling
  • checkSupports microvascular angiogenesis pathways
  • checkInvestigated in connective tissue & tendon recovery research
  • checkPromotes gastric mucosal protection
menu_book

Scientific Literature Abstract

"BPC-157 modulates growth factor expression, including VEGFR2 and bFGF, accelerating cell migration and granulation tissue formation in soft tissue repair models without inducing systemic toxicity or hormonal interference."

hubTarget Receptor Pathways

VEGFR2 (Vascular Endothelial Growth Factor Receptor 2)
FAK (Focal Adhesion Kinase) Activation
Nitric Oxide Synthase (eNOS) Expression
Gastric Endothelial Signaling

Frequently Asked Questions

What tissue types are studied with BPC-157?

Literature focuses on tendons, ligaments, skeletal muscle, and gastric endothelial linings.

Explore Related Scientific Interventions

Metabolic Health₦145,000 / month

Semaglutide Protocol

A GLP-1 receptor agonist studied for appetite modulation and glycemic signaling pathways in metabolic health.

View Full Details arrow_forward
Weight Management₦210,000 / month

Tirzepatide Dual Agonist

Dual GIP and GLP-1 receptor agonist targeting complementary metabolic pathways for body composition and appetite research.

View Full Details arrow_forward
Weight Management₦280,000 / month

Retatrutide Triple Agonist

Triple receptor agonist (GIP, GLP-1, and Glucagon) studied for its potential effects on metabolic rate and lipid mobilization pathways.

View Full Details arrow_forward
gavel

Clinical & Legal Disclaimer

Medical Disclaimer: Information provided on this website is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Product availability, indications, regulatory status, and suitability may vary. Any medical treatment should be considered with an appropriately qualified healthcare professional.

NOVAMET does not guarantee specific weight-loss, metabolic, or treatment outcomes.